What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Biochemistry, Molecular biology, ADP ribosylation factor, Lymphangioleiomyomatosis and Pathology are his primary areas of study.
His research in Biochemistry tackles topics such as Cholera toxin which are related to areas like NAD+ kinase.
His Molecular biology research is multidisciplinary, incorporating elements of Nitric oxide synthase, Transcriptional regulation and Complementary DNA, Gene, Transfection.
His ADP ribosylation factor study also includes
- GTP-binding protein regulators which intersects with area such as Phospholipase D,
- GTP' that connect with fields like Binding protein.
His studies deal with areas such as Thoracic duct and Abdomen as well as Lymphangioleiomyomatosis.
In his study, Gastroenterology is inextricably linked to Respiratory disease, which falls within the broad field of Pathology.
His most cited work include:
- Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs. glutamate at position 298 (479 citations)
- Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. (452 citations)
- Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators (444 citations)
What are the main themes of his work throughout his whole career to date?
Joel Moss focuses on Biochemistry, Molecular biology, Lymphangioleiomyomatosis, ADP ribosylation factor and Pathology.
His Biochemistry study frequently intersects with other fields, such as Cholera toxin.
Joel Moss has researched Molecular biology in several fields, including Amino acid and Complementary DNA, Protein subunit, Gene, Messenger RNA.
The study incorporates disciplines such as Pulmonary function testing and Sirolimus in addition to Lymphangioleiomyomatosis.
Joel Moss usually deals with ADP ribosylation factor and limits it to topics linked to Brefeldin A and Guanine nucleotide exchange factor.
In his work, Pertussis toxin is strongly intertwined with Cyclase, which is a subfield of NAD+ kinase.
He most often published in these fields:
- Biochemistry (38.17%)
- Molecular biology (25.11%)
- Lymphangioleiomyomatosis (20.32%)
What were the highlights of his more recent work (between 2016-2021)?
- Lymphangioleiomyomatosis (20.32%)
- Tuberous sclerosis (10.74%)
- Pathology (13.35%)
In recent papers he was focusing on the following fields of study:
Joel Moss mainly focuses on Lymphangioleiomyomatosis, Tuberous sclerosis, Pathology, Sirolimus and TSC2.
His Lymphangioleiomyomatosis study results in a more complete grasp of Internal medicine.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology.
His Tuberous sclerosis research incorporates themes from Genetics, Lesion, Dermatology, Angiofibroma and Fibrofolliculoma.
His Pathology research includes elements of Buttocks and Cell.
The TSC2 study combines topics in areas such as Cancer research, TSC1 and Mesenchymal stem cell.
Between 2016 and 2021, his most popular works were:
- TRIM23 mediates virus-induced autophagy via activation of TBK1 (80 citations)
- Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline. (72 citations)
- Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase (54 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His primary scientific interests are in Lymphangioleiomyomatosis, Tuberous sclerosis, Pathology, Sirolimus and TSC2.
His research on Internal medicine and Lung is centered around Lymphangioleiomyomatosis.
His Tuberous sclerosis research incorporates elements of Cohort study, Linkage disequilibrium, Chromosome, Gene and Cohort.
His Pathology study integrates concerns from other disciplines, such as Dermatology and Pulmonary carcinoid tumour.
His TSC2 study incorporates themes from Penetrance, Cancer research, TSC1 and Family history.
His biological study spans a wide range of topics, including Arginine and ADP-ribosylation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
